2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Hemangioma
3
Breast Neoplasms
3
Neoplasms
2
Heart Failure
2
Smoldering Multiple Myeloma
1
Postoperative Nausea and Vomiting
1
Pain, Postoperative
1
Pain
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Hyperalgesia
1
Hemangioma, Capillary
1
Essential Hypertension
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Bupivacaine
32
Ropivacaine
19
Dexmedetomidine
19
Saline Solution
18
Morphine
12
Ketamine
12
Sodium Chloride
10
Acetaminophen
10
Pregabalin
9
Lidocaine
9
Control Groups
9
Injections, Epidural
5
Dexamethasone
5
Surgical Procedures, Operative
4
Gabapentin
4
Epinephrine
4
Anesthetics, Local
4
Anesthesia, General
4
Analgesia, Patient-Controlled
4
parecoxib
3
oxycodone-acetaminophen
3
Tea
3
Midazolam
3
Ketorolac
3
Fentanyl
3
Esketamine
3
Dental Occlusion
3
Anti-Inflammatory Agents, Non-Steroidal
3
Analgesics, Opioid
3
Vitamins
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pain, Postoperative
×
Adrenergic beta-Antagonists
×
Clear all
NCT01544959
2018-10-24
PAINFree
Université de Sherbrooke
Phase NA
Completed
84 enrolled